
26.09.2023
Meet Eva Kopecna, Global Head Regulatory Affairs, Medical and Pharmacovigilance
Dedication and expertise are key qualities needed to deliver flexible solutions. We are fortunate to have a group of experts...
Dedication and expertise are key qualities needed to deliver flexible solutions. We are fortunate to have a group of experts...
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets....
Report reflects Acino’s commitment to Environmental, Social, and Governance sustainability including goal of reaching carbon neutrality by 2050. ZURICH, Switzerland,...
In today’s pharmaceutical market, with higher regulatory demands and greater attention to compliance and Quality Assurance, customers are increasingly demanding...
Read the full interview with John Norman in the Executive Forecast magazine and get a glimpse into the innovative strategies...
Milestone Agreement Inaugurates New Partnership and Signals AD Ports Logistics’ Further Expansion into the Global Healthcare & Lifesciences Logistics Sector...
We are pleased to announce that Max Sorokin, has been appointed as Acino’s Chief Financial Officer, effective immediately. Max is...
We are pleased to announce that Andrew Bird, currently Head of META at Acino, will assume the role of interim...
Partnership covers the marketing and distribution of select products including new therapeutic areas of diabetes and hypercholesterolemia, in addition to...